Voyageur Pharmaceuticals Ltd

TSXV:VMCanadaView on OTC Pink - Current Information

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

Contact Information

Headquarters

Dome Tower 800, 333 7 Ave. S.W.CALGARY, AB, Canada T2P 2Z1

Phone

403-923-5944

Fax

403-508-2670

Executives

President, Chief Executive Officer, Director

Brent Willis

Chief Financial Officer

Albert Deslauriers

Chief Operating Officer

Bradly Willis

Chief Science Officer

Iryna Saranchova

Director

Agustin Gago